CCardinal AnalytxBiotech/health1 / 12Read in the app

Pitch deck

Cardinal Analytx's pitch deck

The deck, and the 2 rounds we watched Cardinal Analytx raise afterwards, with the investors each report named.

12 slides2.6MBUSBiotech/health

Read the deckFree account. The deck belongs to Cardinal Analytx, so reading it needs one; everything on this page is public.

What is in it

The deck, slide by slide

Each slide by what it argues. 12 slides against a median of 13 across the 1,712 decks we hold.

median
  1. 1Cover
  2. 2Vision
  3. 3Vision
  4. 4Solution
  5. 5Problem
  6. 6Solution
  7. 7Market
  8. 8Business model
  9. 9Solution
  10. 10Solution
  11. 11Team
  12. 12Team

CoverVisionSolutionProblemMarketBusiness modelTeam

  1. May 2019

    Series B$22M

    John DoerrLeadBlue Shield CaliforniaGuideWell Mutual HoldingPremera Blue Cross

    Reported by FinSMEs

  2. Sept 2017

    Series A$6.1M

    Cardinal Partners/ Premera Blue CrossStanford-StartX

    Reported by FinSMEs

Everyone who backed Cardinal Analytx

Form D

What they told the regulator

Cardinal Analytx filed 3 Form Ds with the SEC

The company reporting its own raise, rather than a journalist reporting it.

$21Msold under the offeringApr 2019most recent filing
Cardinal Analytx pitch deck, cover slide1 / 12

The deck itself

Read Cardinal Analytx's full pitch deck

All 12 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck →Free account. The deck belongs to Cardinal Analytx.

More decks

ModernaBiotech/health1 / 12$675M raised afterHingehealthBiotech/health1 / 15$434M raised afterDispatchHealthBiotech/health1 / 6$397M raised afterTheranosBiotech/health1 / 24$188M raised after

Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.